Protagenic Therapeutics, Inc.
PTIX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$4,487 | -$5,058 | -$1,440 | -$1,554 |
| Dep. & Amort. | $231 | $13 | $13 | $13 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | -$5 | $125 | $236 | $245 |
| Change in WC | -$123 | $448 | $123 | $556 |
| Other Non-Cash | $2,890 | $3,304 | $0 | -$80 |
| Operating Cash Flow | -$1,495 | -$1,167 | -$1,068 | -$820 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $943 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $943 | $0 | $0 | $0 |
| Investing Cash Flow | $943 | $943 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $78 | $0 | $0 |
| Stock Issued | $293 | $395 | $103 | $1,602 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $4,305 | $3,950 | $0 | $0 |
| Financing Cash Flow | $4,305 | $4,423 | $103 | $1,602 |
| Forex Effect | -$80 | -$117 | -$0 | $0 |
| Net Chg. in Cash | $1,849 | $4,082 | -$966 | $783 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $873 | $15 | $1,838 | $1,056 |
| End Cash | $2,722 | $4,096 | $873 | $1,838 |
| Free Cash Flow | -$1,495 | -$1,167 | -$1,068 | -$820 |